Skip to main content
. 2008 Jun;152(3):456–463. doi: 10.1111/j.1365-2249.2008.03650.x

Table 3.

Induced T helper 1 (Th1) and Th2 cytokine-producing CD4+ and CD8+ T cells from peripheral blood of ischaemic stroke patients and controls, following mitogenic stimulation.

Cytokine Group CD4+ T cells (%) P-value* CD8+ T cells (%) P-value*
IFN-γ MC 29·10 ± 9·14 n.s. 63·97 ± 17·59 n.s.
ISs- 25·72 ± 10·59 64·79 ± 15·83
ISs+ 33·23 ± 9·29 68·16 ± 14·71
IL-2 MC 63·77 ± 11·26 n.s. 21·50 ± 8·47 n.s.
ISs- 63·32 ± 12·34 20·07 ± 7·79
ISs+ 63·61 ± 10·93 24·64 ± 3·62
IL-4 MC 0·23 ± 0·18 0·17 ± 0·10
ISs- 1·09 ± 0·95 0·027 0·90 ± 0·97 n.s.
ISs+ 1·04 ± 0·39 0·028 1·33 ± 1·15 0·015
IL-10 MC 0·41 ± 0·21 n.s. 0·48 ± 0·28 n.s.
ISs- 0·37 ± 0·22 0·28 ± 0·20
ISs+ 0·56 ± 0·36 0·30 ± 0·11

Whole blood samples were cultured with phorbol 12-myristate13-acetate/ionomycin for 5 h in the presence of brefeldin A. The values of cytokine-producing cells were calculated as the percentage of CD4+ and CD8+ peripheral T cell populations. The data are expressed as mean ± standard deviation.

*

The post-hoc Tukey test was used to compare MC with ISs- and MC with ISs+. IL, interleukin; IFN, interferon; ISs-, ischaemic stroke patients not receiving statins (n = 17); ISs+, IS patients receiving statins (n = 6); MC, matched controls (n = 7); n.s., not statistically significant.